Literature DB >> 1933270

Fluoro-Gold: composition, and mechanism of uptake.

M W Wessendorf1.   

Abstract

Determining the mechanism by which fluorescent retrograde neuronal tracers are taken up requires knowledge of their composition. It has been claimed that Fluoro-Gold, a retrogradely transported fluorescent neuronal tracer, is 2-hydroxy-4,4'-diamidinostilbene (hydroxystilbamidine), an amidine antibiotic. However, this appears questionable, since the fluorescence spectrograms reported for Fluoro-Gold differ markedly from the spectrograms previously reported for purified hydroxystilbamidine. To help clarify the mechanism by which Fluoro-Gold might be taken up, it was decided to examine its composition and determine whether hydroxystilbamidine was its active agent. Fluoro-Gold was found by mass spectrometry to contain a component with a molecular weight of 280 Da (identical to that of hydroxystilbamidine), and fluorescence spectroscopy demonstrated the existence of a substance with a fluorescence spectrum similar to that of purified hydroxystilbamidine. Although a major fluorescent impurity was also observed, chromatographic separation of different fluorescent components of Fluoro-Gold suggested that the fraction resembling hydroxystilbamidine was responsible for its retrograde labeling of cells. It is concluded that hydroxystilbamidine is the active constituent of Fluoro-Gold. Chemically, hydroxystilbamidine is a weak base. In this respect it resembles True blue, DAPI, Granular blue, bis-benzimide, Nuclear yellow, and several other retrogradely transported molecules. It is suggested that these agents cross cell membranes in their uncharged form and are trapped in lysosomes and endosomes by a favorable pH gradient. Thus, the uptake of this type of retrograde tracer may be an example of a well-understood process occurring widely throughout biological systems: the trapping of weak bases in acidic cellular compartments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933270     DOI: 10.1016/0006-8993(91)90241-m

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Authors:  Negin Nouraei; Lauren Zarger; Justin N Weilnau; Jimin Han; Daniel M Mason; Rehana K Leak
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-12       Impact factor: 4.219

2.  A method to quantify regional axonal transport blockade at the optic nerve head after short term intraocular pressure elevation in mice.

Authors:  Arina Korneva; Julie Schaub; Joan Jefferys; Elizabeth Kimball; Mary Ellen Pease; Manasi Nawathe; Thomas V Johnson; Ian Pitha; Harry Quigley
Journal:  Exp Eye Res       Date:  2020-04-27       Impact factor: 3.467

3.  Retrogradely transported fluorogold accumulates in lysosomes of neurons and is detectable ultrastructurally using post-embedding immuno-gold methods.

Authors:  Stefan Persson; Leif A Havton
Journal:  J Neurosci Methods       Date:  2009-07-23       Impact factor: 2.390

4.  Systemic administration of fluorogold for anatomical pre-labeling of autonomic and motor neurons in the rat spinal cord compromises urodynamic recordings in acute but not long-term studies.

Authors:  Huiyi H Chang; Leif A Havton
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

5.  Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease.

Authors:  Y Sagot; T Rossé; R Vejsada; D Perrelet; A C Kato
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

6.  Triptan-induced latent sensitization: a possible basis for medication overuse headache.

Authors:  Milena De Felice; Michael H Ossipov; Ruizhong Wang; Josephine Lai; Juliana Chichorro; Ian Meng; David W Dodick; Todd W Vanderah; Gregory Dussor; Frank Porreca
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

Review 7.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

8.  mu-Opioid and delta-opioid receptors are expressed in brainstem antinociceptive circuits: studies using immunocytochemistry and retrograde tract-tracing.

Authors:  A E Kalyuzhny; U Arvidsson; W Wu; M W Wessendorf
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

9.  Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Authors:  Eugenia Trushina; Roy B Dyer; John D Badger; Daren Ure; Lars Eide; David D Tran; Brent T Vrieze; Valerie Legendre-Guillemin; Peter S McPherson; Bhaskar S Mandavilli; Bennett Van Houten; Scott Zeitlin; Mark McNiven; Ruedi Aebersold; Michael Hayden; Joseph E Parisi; Erling Seeberg; Ioannis Dragatsis; Kelly Doyle; Anna Bender; Celin Chacko; Cynthia T McMurray
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  A microinjection technique for targeting regions of embryonic and neonatal mouse brain in vivo.

Authors:  Steve Davidson; Hai Truong; Yasushi Nakagawa; Glenn J Giesler
Journal:  Brain Res       Date:  2009-10-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.